Volume 27, Issue 4 pp. 366-372
Article
Full Access

Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis

Joseph W. Karaszewski BS

Joseph W. Karaszewski BS

Department of Neurology and the Brain Research Institute, University of Chicago, Chicago, IL

Search for more papers by this author
Anthony T. Reder MD

Anthony T. Reder MD

Department of Neurology and the Brain Research Institute, University of Chicago, Chicago, IL

Search for more papers by this author
Ricardo Maselli MD

Ricardo Maselli MD

Department of Neurology and the Brain Research Institute, University of Chicago, Chicago, IL

Search for more papers by this author
Margaret Brown BS

Margaret Brown BS

Department of Neurology and the Brain Research Institute, University of Chicago, Chicago, IL

Search for more papers by this author
Barry G. W. Arnason MD

Corresponding Author

Barry G. W. Arnason MD

Department of Neurology and the Brain Research Institute, University of Chicago, Chicago, IL

Department of Neurology, University of Chicago, 5841 S. Maryland Avenue, BH Box 425, Chicago, IL 60637Search for more papers by this author
First published: April 1990
Citations: 68

Abstract

Immune abnormalities, including deficient CD8 lymphocyte-mediated suppression, have been implicated in the progression of multiple sclerosis (MS). The peripheral sympathetic branch of the autonomic nervous system innervates the lymphoid organs and affects immune function. Animals with an ablated sympathetic nervous system develop more severe experimental allergic encephalomyelitis than control animals and exhibit an increased density of betaadrenergic receptors on their lymphocytes. Experimental allergic encephalomyelitis shares many features with MS. Accordingly, we investigated the psychogalvanic skin reflex in patients with rapidly progressive MS and found that 13 patients (57%) lacked this sympathetic-mediated response. The density of beta-adrenergic receptors on lymphocyte subsets was increased in progressive MS, most notably on the CD8 suppressor/cytotoxic subset. B lymphocytes had the greatest number of receptors with 12.1 ± 1.8 fmol/106 cells in control subjects and 18.7 ± 2.6 fmol/106 cells in patients with MS. CD8 lymphocytes possessed an intermediate number of receptors with 3.4 ± 0.4 fmol/106 cells in control subjects and 9.1 ± 1.6 fmol/106 cells in patients with MS. CD4 lymphocytes demonstrated the fewest receptors with 1.2 ± 0.1 fmol/106 cells in control subjects and 1.8 ± 0.4 fmol/106 cells in patients with MS. No differences in the affinity or function (cyclic adenosine monophosphate levels in response to 10−5 M (–)isoproterenol) of the adrenergic receptor were found when patients with progressive MS and control subjects were compared. Autonomic abnormalities in progressive MS and the increased beta-adrenergic receptor density found on CD8 lymphocytes may be related.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me